Nuclear Medicine, Radiology Department, San Francisco VA Medical Center, San Francisco, Calif., USA
Search for other papers by C. Mari Aparici in
Google Scholar
PubMed
Search for other papers by T. Liu in
Google Scholar
PubMed
cancer to a distant, nonregional lymphatic nodal station. Introduction Most thyroid cancers are differentiated, and are classified pathologically as papillary or follicular or variants of these. In the US, papillary thyroid cancer is the most
Search for other papers by Diana Borges Duarte in
Google Scholar
PubMed
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Guilherme Assunção in
Google Scholar
PubMed
Search for other papers by André Couto Carvalho in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
patient. Electronic Health Registry and Primary Care data were used to determine the causes of death. Papillary thyroid cancer treatment and follow-up All patients underwent surgical treatment (total thyroidectomy or totalization of previous sub
Search for other papers by Andrea Palermo in
Google Scholar
PubMed
Search for other papers by Andrea Napolitano in
Google Scholar
PubMed
Search for other papers by Daria Maggi in
Google Scholar
PubMed
Search for other papers by Anda Mihaela Naciu in
Google Scholar
PubMed
Search for other papers by Gaia Tabacco in
Google Scholar
PubMed
Search for other papers by Silvia Manfrini in
Google Scholar
PubMed
Search for other papers by Anna Crescenzi in
Google Scholar
PubMed
Search for other papers by Chiara Taffon in
Google Scholar
PubMed
Search for other papers by Francesco Pantano in
Google Scholar
PubMed
Search for other papers by Bruno Vincenzi in
Google Scholar
PubMed
Search for other papers by Guiseppe Tonini in
Google Scholar
PubMed
Search for other papers by Daniele Santini in
Google Scholar
PubMed
Established Facts It is already known that papillary thyroid cancer arising in a background of Hashimoto thyroiditis shows increased programmed cell death-1 (PD-L1). It is already known that metastases to the thyroid gland are
Search for other papers by Chi-Yu Kuo in
Google Scholar
PubMed
Search for other papers by Po-Sheng Yang in
Google Scholar
PubMed
Search for other papers by Ming-Nan Chien in
Google Scholar
PubMed
Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Shih-Ping Cheng in
Google Scholar
PubMed
Introduction Papillary thyroid cancer (PTC) is the most common endocrine malignancy, and its incidence is rising worldwide. Although PTC generally follows an indolent course, an increase in the mortality rate for advanced-stage PTC has been
Search for other papers by Lan Wu in
Google Scholar
PubMed
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Search for other papers by Chen-Yang Feng in
Google Scholar
PubMed
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Search for other papers by Yu Chen in
Google Scholar
PubMed
Search for other papers by Wei-Wei Liu in
Google Scholar
PubMed
Search for other papers by Miao-Bian Liang in
Google Scholar
PubMed
Search for other papers by Zike Zhang in
Google Scholar
PubMed
Search for other papers by Jun Yang in
Google Scholar
PubMed
Search for other papers by Su-Mei Cao in
Google Scholar
PubMed
Search for other papers by Mengmeng Li in
Google Scholar
PubMed
not have caused them harm if it was left undiscovered ( 4 ). The progressive introduction and wide use of new diagnostic techniques have likely led to increased detection of low-risk tumors ( 5 ), particularly papillary thyroid cancer (PTC) subtypes
Search for other papers by Helmi Khadra in
Google Scholar
PubMed
Search for other papers by Ahmed Deniwar in
Google Scholar
PubMed
Search for other papers by Khuzema Mohsin in
Google Scholar
PubMed
Search for other papers by Dominique Monlezun in
Google Scholar
PubMed
Search for other papers by Emad Kandil in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer has been steadily increasing in the United States. This has been attributed in part due to the increased detection of small papillary thyroid cancer (PTC) [ 1 ]. As most thyroid cancers initially
Search for other papers by Giacomo Sturniolo in
Google Scholar
PubMed
Search for other papers by Carles Zafon in
Google Scholar
PubMed
Search for other papers by Mariacarla Moleti in
Google Scholar
PubMed
Search for other papers by Josep Castellví in
Google Scholar
PubMed
Search for other papers by Francesco Vermiglio in
Google Scholar
PubMed
Search for other papers by Jordi Mesa in
Google Scholar
PubMed
Dong W, Zhang H, Li J, Guan H, He L, Wang Z, Shan Z, Teng W: Estrogen induces metastatic potential of papillary thyroid cancer cells through estrogen receptor α and β. Int J Endocrinol 2013;2013:941568. 10.1155/2013/941568 24222765 9 Hiasa Y
Search for other papers by Luca Damiani in
Google Scholar
PubMed
Search for other papers by Sabrina Lupo in
Google Scholar
PubMed
Search for other papers by Roberta Rossi in
Google Scholar
PubMed
Search for other papers by Stefania Bruni in
Google Scholar
PubMed
Search for other papers by Mirco Bartolomei in
Google Scholar
PubMed
Search for other papers by Stefano Panareo in
Google Scholar
PubMed
Search for other papers by Paola Franceschetti in
Google Scholar
PubMed
Search for other papers by Paolo Carcoforo in
Google Scholar
PubMed
Search for other papers by Giovanni Lanza in
Google Scholar
PubMed
Search for other papers by Stefano Pelucchi in
Google Scholar
PubMed
Endocrine Unit, Azienda Ospedaliero-Universitaria di Ferrara, Cona/Ferrara, Italy
Search for other papers by Ettore Degli Uberti in
Google Scholar
PubMed
Endocrine Unit, Azienda Ospedaliero-Universitaria di Ferrara, Cona/Ferrara, Italy
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
alternative events in the etiopathogenesis of PTC. Oncogene 2003; 22: 4578–4580. 4 Omry-Orbach G: Risk stratification in differentiated thyroid Cancer: an ongoing process. Rambam Maimonides Med J 2016; 7. 5 Xing M: BRAF mutation in papillary
Search for other papers by Neslihan Kurtulmus in
Google Scholar
PubMed
Search for other papers by Burak Ertas in
Google Scholar
PubMed
Search for other papers by Yesim Saglican in
Google Scholar
PubMed
Search for other papers by Hakan Kaya in
Google Scholar
PubMed
Search for other papers by Umit Ince in
Google Scholar
PubMed
Search for other papers by Mete Duren in
Google Scholar
PubMed
Introduction Papillary thyroid cancer (PTC) is the most common type of endocrine cancer [ 1 ]. It originates from follicular epithelial cells and usually has a slow progression with a good prognosis. However, of note, it presents with a high
Department of Endocrinology and Diabetes, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
Search for other papers by Saleha Babli in
Google Scholar
PubMed
Search for other papers by Richard J. Payne in
Google Scholar
PubMed
Search for other papers by Elliot Mitmaker in
Google Scholar
PubMed
Search for other papers by Juan Rivera in
Google Scholar
PubMed
Introduction Papillary thyroid cancer (PTC) is the most common form of thyroid cancer, comprising approximately 80% of all thyroid cancers [ 1 , 2 ]. Chronic lymphocytic thyroiditis (CLT) is an autoimmune disease characterized by widespread